Elme Communities (ELME)

Marinus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Marinus Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $18.25, which forecasts a 11.08% increase in the stock price over the next year. The lowest target is $17 and the highest is $19.

Price Target: $18.25 (+11.08%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$17	$18.25	$19	$19
Change	+3.47%	+11.08%	+15.64%	+15.64%

* Price targets were last updated on Feb 20, 2025.

Analyst Ratings

The average analyst rating for Marinus Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	5	5	5	5	5	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
James Feldman Wells Fargo	Wells Fargo	Hold Maintains $17 → $19	Hold	Maintains	$17 → $19	+15.64%	Feb 20, 2025
Michael Mueller JP Morgan	JP Morgan	Buy → Hold Downgrades $19 → $18	Buy → Hold	Downgrades	$19 → $18	+9.56%	Dec 17, 2024
Cole Bardawill Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Oct 21, 2024
Anthony Paolone JP Morgan	JP Morgan	Buy Maintains $17 → $19	Buy	Maintains	$17 → $19	+15.64%	Sep 16, 2024
Blaine Heck Wells Fargo	Wells Fargo	Hold Maintains $14 → $17	Hold	Maintains	$14 → $17	+3.47%	Sep 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

253.64M

Increased by 4.84%

from 241.94M

Revenue Next Year

255.67M

Increased by 0.80%

from 253.64M

EPS This Year

-0.14

from -0.15

EPS Next Year

-0.07

from -0.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	176.00M	169.15M	209.38M	227.91M	241.94M	253.64M	255.67M	254.51M
Revenue Growth	-0.42%	-3.89%	23.78%	8.85%	6.15%	4.84%	0.80%	-0.45%
EPS	-0.20	0.19	-0.36	-0.61	-0.15	-0.14	-0.07	-0.03
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	261.5M	270.9M	275.1M
Avg	253.6M	255.7M	254.5M
Low	243.3M	234.5M	236.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	8.1%	6.8%	7.6%
Avg	4.8%	0.8%	-0.5%
Low	0.5%	-7.6%	-7.5%

EPS Forecast

EPS	2025	2026	2027
High	-0.15	-0.07	-0.03
Avg	-0.14	-0.07	-0.03
Low	-0.14	-0.07	-0.03

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.